Arizona and other states that impose heavy restrictions on embryonic stem cell research might not get the full benefits that come with President Barack Obama's decision to lift federal funding limits on such research, said BIO President James Greenwood. He added that the biotechnology industry faces several challenges this year, including health care reform and the recession.

Related Summaries